top of page
S Greene Headshot_Faculty.jpg

Stephen J. Greene, MD

Associate Professor

Duke University School of Medicine

Duke Clinical Research Institute

Dr. Greene is a heart failure cardiologist and his research focuses on improving quality of care and outcomes for patients with heart failure.  His work includes leadership roles within multiple national and international heart failure registries characterizing the quality of heart failure care. These registry programs include the CHAMP-HF registry, American Heart Association’s Get With The Guidelines Heart Failure registry, the VICTORIA registry, and the CARE-HK in HF registry.  He is the coordinating center Principal Investigator for the American Heart Association’s Get With The Guidelines Heart Failure registry. He has also been a co-investigator and co-author of multiple national and international heart failure trials studying medical therapies for heart failure, including the ASTRONAUT, SOCRATES-Reduced, COMPOSE, TRANSFORM-HF, and VELOCITY trials. Dr. Greene’s collaborative work has led to more than 400 publications in peer-reviewed journals.

Presenting Modules:

 

Interdisciplinary Approach to Enhance Goal-Directed Medication Therapy in CKM: Strategies to manage hyperkalemia

Today treating patients with overlapping cardiovascular, kidney and metabolic (CKM) syndrome is top of mind. While our therapeutic toolkit has expanded, the real and perceived risks of hyperkalemia frequently act as barriers to prescribing foundational Goal-Directed Medication Therapies (GDMT).

This module addresses the shifting landscape of cardiovascular risk factors-specifically the rising epidemics of obesity, chronic kidney disease (CKD), and type 2 diabetes-and explores how an interdisciplinary approach can manage serum potassium levels without sacrificing life-saving, disease-modifying therapies.

AKHOMM is fiscally sponsored by the Alliance for Integrated Medication Management (AIMM), a non-profit organization.

All content © Advancing Kidney Health through Optimal Medication Management 2026

  • X
  • LinkedIn
bottom of page